DIPEPTIDYL PEPTIDASE-IV INHIBITORY ACTIVITIES OF MEDICINAL PLANTS: TERMINALIA ARJUNA, COMMIPHORA MUKUL, GYMNEMA SYLVESTRE, MORINDA CITRIFOLIA, EMBLICA OFFICINALIS


Manjusha K Borde, Rajesh Kumar Suman, Ipseeta Ray Mohanty, Y A Deshmukh

Abstract


Objective: The present study was designed to screen the dipeptidyl peptidase-IV (DPP-IV) inhibitory ability of hydroalcoholic extracts of Terminalia
arjuna, Commiphora mukul, Gymnema sylvestre, Morinda citrifolia, and Emblica officinalis and compare their inhibitory activity with the synthetic
DPP-IV inhibitors (Sitagliptin and Vildagliptin). The aim of the study was to identifying indigenous sources of DPP-IV inhibitors for the management
of type II diabetes mellitus as alternatives to their synthetic counterparts.
Methods: The hydroalcoholic extract of T. arjuna, C. mukul, G. sylvestre, M. citrifolia, E. officinalis and synthetic DPP-IV inhibitors (Sitagliptin and
Vildagliptin) were tested in vitro for DPP-IV inhibitory activity.
Results: The DPP-IV inhibitory activity of synthetic drugs Vildagliptin was found to be 90.42±7.84% and Sitagliptin 84.67±8.21%. The DPP-IV
Inhibitory activity of T. arjuna was found to be 83.39±7.58%, C. mukul: 92.97± 8.45%, G. sylvestre: 16.98±1.69%, M. citrifolia: 24.64±2.24%, and
E. officinalis: 85.95±7.16%. C. mukul extract showed superior inhibitory activity than reference standard drugs (Sitagliptin and Vildagliptin).
Conclusion: C. mukul, T. arjuna, and E. officinalis extracts possess significant DPP-IV Inhibitory activity while G. sylvestre and M. citrifolia failed to
markedly inhibit DPP-IV enzyme.
Keywords: Type II diabetes mellitus, Dipeptidyl peptidase-IV inhibitors, Plant extracts, In vitro assay.


| PDF |

References


REFERENCES

Drucker DJ. Enhancing incretin action for the treatment of Type 2

diabetes. Diabetes Care 2003;26(10):2929-40.

Kieffer TJ, Habener JF. The glucagon-like peptides. Endocr Rev

;20(6):876-913.

Deacon CF, Johnsen AH, Holst JJ. Degradation of glucagon-like

peptide-1 by human plasma in vitro yields an N-terminally truncated

peptide which is a major endogenous metabolite in vivo. J Clin

Endocrinol Metab 1995;80:952-7.

Lambeir AM, Durinx C, Scharpé S, De Meester I. Dipeptidyl-peptidase

IV from bench to bedside: An update on structural properties, functions,

and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci

;40:209-94.

Fredenrich A, Palle S, Canivet B. Dipeptidyl peptidase inhibitors:

A new step towards normoglycemia. Open Endocrinol J 2009;3:16-21.

Matteucci E, Giampietro O. Dipeptidyl peptidase-4 inhibition:

Linking chemical properties to clinical safety. Curr Med Chem

;18(31):4753-60.

Nicolau Ramis J, Masmiquel Comas L. The new antidiabetic agents

in the firing line. safety reasons or witch hunt?. Endocrinol Nutr

;59(1):1-8.

Monami M, Dicembrini I, Mannucci E. Dipeptidyl peptidase-4

inhibitors and pancreatitis risk: A meta-analysis of randomized clinical

trials. Diabetes Obes Metab 2014;16(1):48-56.

Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC. Pancreatitis,

pancreatic, and thyroid cancer with glucagon-like peptide-1-based

therapies. Gastroenterology 2011;141(1):150-6.

Yogisha S, Raveesha KA. Dipeptidyl peptidase IV inhibitory activity of

Mangifera indica. J Nat Prod 2010;3:76-9.

Bharti SK, Sharma NK, Kumar A, Krishnan S, Gupta AK, Jaiswal SK.

Dipeptidyl peptidase IV inhibitory activity of seed extracts of

Castanospermum austral and molecular docking of their alkaloids.

Topclass J Herb Med 2012;1(1):1-7.

Mardanyan S, Sharoyan S, Antonyan A, Zakaryan N. Dipeptidyl

peptidase IV and adenosine deaminase inhibition by 12. Armenian

planta and antidiabetic drugs. Int J Diabetes Metab 2011;19:69-74.

Chakrabarti R, Singh B, Narendra P, Varghese N, Vanchhawng L,

Shihabudeen MS, et al. Dipeptidyl peptidase- IV inhibitory activity of

Berberis aristata. J Nat Prod 2011;4:158-63.

Al-masri IM, Mohammad MK, Tahaa MO. Inhibition of dipeptidyl

peptidase IV (DPP IV) is one of the mechanisms explaining the

hypoglycemic effect of berberine. J Enzyme Inhib Med Chem

;24(5):1061-6.

Singh AK, Jatwa R, Joshi J. Cytoprotective and dipeptidyl peptidase-IV

(DPP-IV/CD26) inhibitory roles of Ocimum sanctum and Momordica

charantia extracts. Asian J Pharm Clin Res 2014;7(1):115-20.

Bisht R, Bhattacharya S, Jaliwala YA. Evaluating the use of Desmodium

gangeticum as alpha glucosidase and DPPIV inhibitor for Type-II

diabetes. Am J Phytomed Clin Ther 2014;2(4):530-9.

Kilari EK, Mullapudi B, Moka PV, Silakabattini K, Nelli G. Inhibition

of DPP-IV activity and enhancement of GLP-1 expression by aqueous

peel extracts of Punica granatum in albino wistar rats. J Glob Trends

Pharm Sci 2014;5(2):1528-41.

Barve K, Bhonsle N. Commiphora mukul prevents myocardial

dysfunction in streptozotocin induced diabetic rats. Pharm Crops

;5(5):61-6.

Shirazi L, Salehi I, Moradkhani SH. Evaluation of analgesic effects of

clove extracton male offspring of surrey female miceduring lactation.

Armaghane - Danesh 2015;19(10):861-9.

Bellamkonda R, Rasineni K, Singareddy SR, Kasetti RB, Pasurla R,

Chippada AR, et al. Anti-hyperglycemic and antioxidant activities of

alcoholic extract of Commiphora mukul gum resin in streptozotocin

induced diabetic rats. Pathophysiology 2011;18(4):255-61.

Akhtar MS, Ramzan A, Ali A, Ahmad M. Effect of Amla fruit (Emblica

officinalis Gaertn.) on blood glucose and lipid profile of normal subjects

and Type 2 diabetic patients. Int J Food Sci Nutr 2011;62(6):609-16.

Nain P, Saini V, Sharma S, Nain J. Antidiabetic and antioxidant potential

of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced

Type-2 diabetes mellitus (T2DM) rats. J Ethnopharmacol

;142(1):65-71.

Morshed MA, Haque A, Rokeya B, Ali L. Anti-hyperglycemic

and lipid lowering effect of Terminalia arjuna bark extract on

streptozotocin indiced Type 2 diabetic model rats. Int J Pharm Pharm

Sci 2011;3(4):450-4.

Parveen K, Khan R, Siddiqui WA. Antidiabetic effects afforded by

Terminalia arjuna in high fat-fed and streptozotocin - induced Type 2

diabetic rats. Int J Diabetes Metab 2011;19:23-33




About this article

Title

DIPEPTIDYL PEPTIDASE-IV INHIBITORY ACTIVITIES OF MEDICINAL PLANTS: TERMINALIA ARJUNA, COMMIPHORA MUKUL, GYMNEMA SYLVESTRE, MORINDA CITRIFOLIA, EMBLICA OFFICINALIS

Date

01-05-2016

Additional Links

Manuscript Submission

Journal

Asian Journal of Pharmaceutical and Clinical Research
Vol 9 Issue 3 (May-June) 2016 Page: 180-182

Print ISSN

0974-2441

Online ISSN

2455-3891

Statistics

2383 Views | 488 Downloads

Authors & Affiliations

Manjusha K Borde
MGM Medical college
India

Rajesh Kumar Suman
MGM Medical college
India

Ipseeta Ray Mohanty
MGM Medical college

Y A Deshmukh
MGM Medical college


Article Tools


Email this article (Login required)
Email the author (Login required)

Refbacks

  • There are currently no refbacks.